Wall Street analyst estimates for Nexalin Technology, Inc. (NXL): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| Price / Book | 2.28 |
| EV / EBITDA | -0.30 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $207383 | $242914 | $144065 | $1.3M | $110748 | $168721 | $301647 |
| Cost of Revenue | $218210 | $29039 | $21442 | $363212 | $25688 | $36593 | $61373 |
| Gross Profit | -$10827 | $213875 | $122623 | $958145 | $85060 | $132128 | $240274 |
| Research & Development | 0 | 0 | $139000 | $511000 | $1.9M | $1.2M | $1.1M |
| Selling, General & Admin | $1.5M | $3.5M | $6.1M | $2.8M | $3.9M | $6.7M | $7.5M |
| Operating Expenses | $1.5M | $3.5M | $6.1M | $2.8M | $5.8M | $7.9M | $8.6M |
| Operating Income | -$1.5M | -$3.3M | -$6.0M | -$1.8M | -$5.7M | -$7.8M | -$8.4M |
| EBITDA | -$1.5M | -$3.3M | -$6.0M | -$1.6M | -$4.6M | -$7.6M | -$8.2M |
| Interest Expense | $80989 | $78681 | $82319 | $59382 | $38835 | 0 | 0 |
| Pre-tax Income | -$5.0M | -$3.4M | -$6.1M | -$1.7M | -$4.6M | -$7.6M | -$8.2M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$5.0M | -$3.4M | -$6.1M | -$1.7M | -$4.6M | -$7.6M | -$8.2M |
| EPS | $-20.70 | $-14.10 | $-24.90 | $-6.90 | $-18.90 | $-24.90 | $-15.00 |
| EPS (Diluted) | $-20.70 | $-14.10 | $-24.90 | $-6.90 | $-18.90 | $-24.90 | $-15.00 |
| Shares Outstanding (Diluted) | $242665 | $242665 | $242665 | $242885 | $245234 | $307192 | $546415 |
Price
| Price | $4.92 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Related companies: CLGN · ENLV · HBIO · IINN · MODD · NRXS · RBOT
Explore sector: Healthcare · Medical - Devices
More sections of NXL: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks